Table 1.
Characteristics | Before treatment | 4 months after treatment |
---|---|---|
25-hydroxy vitamin D (ng/mL) | 38.19 | 38.29 |
β-collagen degradation product (pg/mL) | 527.5 | 541.2 |
Total type I collagen amino terminal propeptide (ng/mL) | 134.60 | 66.67 |
N-terminal molecular fragment of osteocalcin (ng/mL) | 33.55 | 21.71 |
Calcitonin (pg/mL) | – | 2.55 |
Bone-specific alkaline phosphatase (μg/L) | 27.6 | 27.2 |
Parathormone (pg/mL) | 26.7 | 21.6 |
Alkaline phosphatase (U/L) | 131 | 124 |
Alanine transaminase (U/L) | 16 | 29 |
Total calcium (mmol/L) | 2.55 | 2.62 |
Phosphorus (mmol/L) | 1.12 | 1.37 |
Creatinine (μmol/L) | 49.3 | 63.8 |